News

Lymphoma Research Foundation to Host Annual Gala at New York’s Historic Plaza Hotel

A Night “Powered by Innovation” Set to Culminate Blood Cancer Awareness Month in September New…

FDA Approves Copanlisib for Relapsed Indolent Follicular Lymphoma

New York, NY (September 14, 2017) – The U.S. Food and Drug Administration (FDA) announced…

Lymphoma Research Foundation Announces Partnership with Annals of Lymphoma

The Lymphoma Research Foundation announced the recipients of its 2017 Postdoctoral Fellowship Grants, representing more than $700,000 in additional funding for leading lymphoma researchers in the first five years of their careers.

LRF Publishes Recommendations on Adolescent and Young Adult Lymphoma Research

Findings from the 2015 Lymphoma Research Foundation scientific symposium on adolescent/young adult (AYA) lymphomas have…

More than 100 Buildings Worldwide Will Join the Lymphoma Research Foundation to Light Red to Raise Awareness for Blood Cancer

Lymphoma Research Foundation’s Premier Light it Red for Lymphoma Initiative Expected to Reach Millions During…

FDA Approves Ibrutinib to Treat Chronic Graft Versus Host Disease

New York, NY (August 3, 2017) – New York, NY – The U.S. Food and…

Lymphoma Research Foundation Makes Additional $700,000 Investment in Young Investigators

Lymphoma Research Foundation Announces Scientific Advisory Board Chair Thomas M. Habermann for FY 2018-2019

The Nation’s Premier Lymphoma-Specific Research Organization Also Adds Four Experts to Industry Leading SAB New…

FDA Approves Subcutaneous Rituximab for Treatment of Various Lymphomas

New York, NY (June 5, 2017) – The U.S. Food and Drug Administration (FDA) announced…

Second Annual Swirl: Chicago Wine Tasting Event Raises More Than $105,000

Local wine and food patrons gather in support of the Lymphoma Research Foundation’s mission Chicago,…